- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02355171
Personalize My Treatment (PMT) Registry (PMT)
May 17, 2023 updated by: Exactis Innovation
A Large-scale Longitudinal Oncology Registry
The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer patients willingly consent to provide residual, clinical samples (surplus after diagnostic testing) of their tumors for cancer research, to give access to their medical record for data collection and then followed prospectively throughout the trajectory of their illness.
They further willingly consent to be recontacted for being informed of other research projects, including clinical trials.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kostas Trakas, PhD
- Phone Number: 514-282-4523
- Email: registration@exactis.ca
Study Contact Backup
- Name: Suzan McNamara, PhD
- Phone Number: 514-282-4523
- Email: smcnamara@exactis.ca
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4N2
- Recruiting
- Tom Baker Cancer Centre
-
Contact:
- Tracy Xu
- Email: Tracy.Xu@albertahealthservices.ca
-
Principal Investigator:
- Steven Yip, MD
-
Sub-Investigator:
- Pinaki Bose, PhD
-
Edmonton, Alberta, Canada, T6G 1Z2
- Recruiting
- Cross Cancer Institute
-
Principal Investigator:
- Quincy Chu, MD
-
-
New Brunswick
-
Moncton, New Brunswick, Canada, E1C 2Z3
- Recruiting
- Centre Hospitalier Universitaire Dr-Georges-L.-Dumont
-
Contact:
- Stéphanie Crapoulet
- Phone Number: 506-862-4221
- Email: Stephanie.Crapoulet@vitalitenb.ca
-
Principal Investigator:
- Eve St-Hilaire, MD
-
Moncton, New Brunswick, Canada, E1C 6Z8
- Recruiting
- The Moncton Hospital
-
Contact:
- Ian Chute, MSc
- Email: Ian.Chute@HorizonNB.ca
-
Contact:
- Trina Mullin, BSc
- Email: Trina.Mullin@horizonnb.ca
-
Principal Investigator:
- Mahmoud Abdelsalam, MD
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 1V8
- Recruiting
- QE II Health Sciences Centre
-
Contact:
- John Fris
- Email: john.fris@nshealth.ca
-
Principal Investigator:
- Zhaolin Xu, MD
-
Principal Investigator:
- Drew Bethune, MD
-
-
Ontario
-
London, Ontario, Canada
- Recruiting
- London Health Science Centre
-
Contact:
- Lee-Anne Pickard, RN
- Email: LeeAnne.Pickard@lhsc.on.ca
-
Principal Investigator:
- Stephen Welch, MD
-
Ottawa, Ontario, Canada, K1H 8L6
- Recruiting
- The Ottawa Hospital
-
Contact:
- Nathalie Tremblay
- Email: natremblay@ohri.ca
-
Principal Investigator:
- Arif Awan, MD
-
Toronto, Ontario, Canada, M4N 3M5
- Recruiting
- Odette Cancer Centre - Sunnybrook Hospital
-
Contact:
- Donna Morgan
- Email: dmorgan1@sunnybrook.ca
-
Principal Investigator:
- Helen MacKay, MD
-
-
Quebec
-
Montreal, Quebec, Canada, H2X 0A9
- Recruiting
- Centre Hospitalier de l'Universite de Montreal
-
Contact:
- Adriana Orimoto
- Email: adriana.mari.orimoto.chum@ssss.gouv.qc.ca
-
Principal Investigator:
- Fred Saad, MD
-
Montreal, Quebec, Canada, H3T 1E2
- Recruiting
- Jewish General Hospital
-
Contact:
- Caterina Marcangione
- Email: cmarcangione@jgh.mcgill.ca
-
Contact:
- Benedicte Foveau
- Email: bfoveau@ladydavis.ca
-
Principal Investigator:
- Mark Basik, MD
-
Montreal, Quebec, Canada, H4A 3J1
- Recruiting
- MUHC McGill University Health Center
-
Principal Investigator:
- Jonathan Spicer, MD
-
Contact:
- Avik Sengupta
- Email: aviksenguptacanada@gmail.com
-
Québec, Quebec, Canada, H3T 1Y6
- Recruiting
- Centre Hospitalier Universitaire de Québec - Université Laval
-
Contact:
- Jean-Charles Hogue, PhD
- Email: Jean-Charles.Hogue@crchudequebec.ulaval.ca
-
Principal Investigator:
- Dominique Boudreau, MD
-
Sherbrooke, Quebec, Canada, J1G 2E8
- Recruiting
- Centre Hospitalier Universitaire de Sherbrooke
-
Contact:
- Noémie Poirier
- Email: noemie.poirier.ciussse-chus@ssss.gouv.qc.ca
-
Contact:
- Suzanne Maltais
- Email: suzanne.maltais.ciussse-chus@ssss.gouv.qc.ca
-
Principal Investigator:
- Julie Carrier, MD
-
Trois-Rivières, Quebec, Canada, G8Z 3R9
- Recruiting
- CIUSSS de la Mauricie-et-du-Centre-du-Québec - Centre Hospital Régional
-
Contact:
- Marie-Eve Caron
- Email: marie-eve_caron_chrtr@ssss.gouv.qc.ca
-
Contact:
- Julie Samson
- Email: julie_samson_ciusssmcq@ssss.gouv.qc.ca
-
Principal Investigator:
- Francois Vincent, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Cancer patients with all solid tumor types.
Description
Age of majority in the province of recruitment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary objective of PMT is to create a collection of cancer patient biospecimens and annotated data that will be used for clinical trial matching and to advance cancer research.
Time Frame: Longitudinal
|
Longitudinal
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: David Bouffard, PhD, Exactis Innovation
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (Anticipated)
July 1, 2025
Study Completion (Anticipated)
July 1, 2025
Study Registration Dates
First Submitted
January 30, 2015
First Submitted That Met QC Criteria
January 30, 2015
First Posted (Estimate)
February 4, 2015
Study Record Updates
Last Update Posted (Actual)
May 18, 2023
Last Update Submitted That Met QC Criteria
May 17, 2023
Last Verified
December 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- PMT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The BDAC (Biospecimen and Data Access Committee) authorizes access requests from researchers to the PMT Platform's biospecimens and data.
It meets as needed to review requests in accordance with the PMT Biospecimen and Data Access Policy.
Requests will be evaluated based on scientific merit, availability of sample and alignment with the mission of the PMT Platform and Exactis.
BDAC is responsible for verifying that the proposed project has received appropriate ethics approval and proof of such approval has been provided.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States